In a report released today, Jason Gerberry from Bank of America Securities maintained a Buy rating on Royalty Pharma (RPRX – Research Report).
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback